FDA Adverse Event Injury Summary report: N

GORE PRECLUDE MVP DURA SUBSTITUTE

MDR report key: 1332689 · Received February 28, 2009

Report

Report Number
2017233-2009-00123
Event Type
Injury
Date Received
February 28, 2009
Date of Event
January 1, 2009
Report Date
February 27, 2009
Manufacturer
W.L. GORE & ASSOCIATES
Product Code
GXQ
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
CA, US
Reporter Occupation
PHYSICIAN

Narratives

Additional Manufacturer Narrative · 1

DEVICE NOT AVAILABLE FOR EVAL. ATTEMPTING TO OBTAIN ADDITIONAL INFO. LITERATURE CITATION: CHAPPELL, E.T., PARE, L., SALEHPOUR, M., MATTHEWS, M., MIDDLEHOF, C. "GORE PRECLUDE MVP DURA SUBSTITUTE APPLIED AS A NONWATERTIGHT 'UNDERLAY' GRAFT FOR CRANIOTOMIES: PRODUCT AND TECHNIQUE EVAL." SURGICAL NEUROLOGY 71 (2009) 126-129.

Description of Event or Problem · 1

IN EARLY 2009, A GORE ASSOCIATE BECAME AWARE OF A PUBLISHED STUDY INVOLVING THE USE OF GORE PRECLUDE MVP DURA SUBSTITUTE (MVP). A SERIES OF SUBJECTS UNDERGOING CRANIOTOMY HAD THEIR DURA RECONSTRUCTED USING A NONWATERTIGHT UNDERLAY GRAFTING TECHNIQUE WITH MVP. IT WAS DETERMINED FROM THE ARTICLE THAT FOUR OF THE STUDY SUBJECTS "EXPERIENCED WOUND DEHISCENCE OR MORE ADVANCED INFECTIONS THAT REQUIRED FURTHER SURGERY." TWO OF THOSE FOUR SUBJECTS REQUIRED REMOVAL OF THE MVP DUE TO INFECTION. OF THESE FOUR SUBJECTS, IT IS UNK AT THIS TIME THE EXACT NUMBER OF INFECTIONS VERSUS WOUND DEHISCENCE. NONE OF THE COMPLICATIONS IN THE STUDY WERE DIRECTLY ATTRIBUTED TO THE USE OF MVP, BUT RATHER WERE ATTRIBUTED TO THE SURGICAL UNDERLAY TECHNIQUE USED. GORE IS CURRENTLY ATTEMPTING TO OBTAIN ADDITIONAL INFO FROM THE STUDY SITE AND/OR STUDY PHYSICIAN (PI).

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
1 GORE PRECLUDE MVP DURA SUBSTITUTE NONE GXQ W.L. GORE & ASSOCIATES WLG102

Patients

Seq Age Sex Outcome Treatment
1 Required Intervention